Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Demel I, Skopal D, Šafránková E, Rozsívalová P, Jindra P, Šrámek J, Turková A, Vydra J, Labská K, Vedrová J, Čerňan M, Szotkowski T, Móciková H, Hynková L, Šušol O, Kováčová I, Belada D, Hájek R. Demel I, et al. Among authors: szotkowski t. Ann Hematol. 2024 Mar;103(3):981-992. doi: 10.1007/s00277-023-05572-0. Epub 2023 Dec 14. Ann Hematol. 2024. PMID: 38092996 Free PMC article.
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].
Indrák K, Hubácek J, Mayer J, Voglová J, Jarosová M, Krahulová M, Malý J, Faber E, Penka M, Kmonícek M, Jebavý L, Szotkowski T, Knotková R, Hlusí A, Zapletalová J. Indrák K, et al. Among authors: szotkowski t. Vnitr Lek. 2001 Sep;47 Suppl 1:48-56. Vnitr Lek. 2001. PMID: 11693063 Clinical Trial. Czech.
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
Penka M, Schwarz J, Pavlík T, Pytlík R, Doubek M, Dulícek P, Pospísilová D, Kissová J, Hlusí A, Schützová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Lhotanová T, Bubeník B, Zapletal O, Vránová M, Micaníková M, Dusek L. Penka M, et al. Among authors: szotkowski t. Vnitr Lek. 2007 Jun;53(6):653-61. Vnitr Lek. 2007. PMID: 17702125 Czech.
Thrombin Generation Testing in Patients with Myelofibrosis.
Palova M, Slavik L, Hlusi A, Szotkowski T, Ulehlova J, Divoka M, Navratilova J, Papajik T. Palova M, et al. Among authors: szotkowski t. Clin Lab. 2018 Sep 1;64(9):1373-1383. doi: 10.7754/Clin.Lab.2018.180204. Clin Lab. 2018. PMID: 30274004
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.
Raida L, Kuba A, Rusinakova Z, Szotkowska R, Skoumalova I, Faber E, Szotkowski T, Rohon P, Hubacek J, Indrak K, Pikalova Z, Jarosova M, Divoka M, Langova K, Papajik T. Raida L, et al. Among authors: szotkowski t. Neoplasma. 2017;64(5):762-769. doi: 10.4149/neo_2017_515. Neoplasma. 2017. PMID: 28592129
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression could be an effective approach to patients with acute lymphoblastic leukemia.
Raida L, Rusinakova Z, Szotkowska R, Kuba A, Faber E, Rohon P, Szotkowski T, Hubacek J, Pikalova Z, Jarosova M, Divoka M, Indrak K, Langova K, Skoumalova I, Papajik T. Raida L, et al. Among authors: szotkowski t. Neoplasma. 2015;62(5):805-11. doi: 10.4149/neo_2015_097. Neoplasma. 2015. PMID: 26278139
[What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
Penka M, Schwarz J, Pavlík T, Pytiĺk R, Doubek M, Dulícek P, Kissová J, Hlusi A, Schutzová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Dusek L. Penka M, et al. Among authors: szotkowski t. Vnitr Lek. 2008 Jul-Aug;54(7-8):775-82. Vnitr Lek. 2008. PMID: 18780577 Czech.
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic.
Szotkowski T, Muzik J, Voglova J, Koza V, Maaloufova J, Kozak T, Jarosova M, Michalova K, Zak P, Steinerova K, Vydra J, Lanska M, Katrincsakova B, Sicova K, Pavlik T, Dusek L, Indrak K. Szotkowski T, et al. Neoplasma. 2010;57(6):578-89. doi: 10.4149/neo_2010_06_578. Neoplasma. 2010. PMID: 20845997
57 results